Article Versions Notes

Hüttl M, Markova I, Miklankova D, Zapletalova I, Poruba M, Racova Z, Vecera R, Malinska H. The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model. Pharmaceutics. 2022; 14(1):45. https://doi.org/10.3390/pharmaceutics14010045

Hüttl, Martina, Irena Markova, Denisa Miklankova, Iveta Zapletalova, Martin Poruba, Zuzana Racova, Rostislav Vecera, and Hana Malinska. 2022. "The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model" Pharmaceutics 14, no. 1: 45. https://doi.org/10.3390/pharmaceutics14010045

Hüttl, M., Markova, I., Miklankova, D., Zapletalova, I., Poruba, M., Racova, Z., Vecera, R., & Malinska, H. (2022). The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model. Pharmaceutics, 14(1), 45. https://doi.org/10.3390/pharmaceutics14010045